| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |